We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current PLSH market cap is 2.44M. The company's latest EPS is USD -0.4542 and P/E is -0.31.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 346k | 2.07M | 2.06M | 1.63M | 2.39M |
| Operating Income | -10.67M | -5.98M | -5.94M | -5.65M | -5.55M |
| Net Income | -10.39M | -9.46M | -4.78M | -9.14M | -8.02M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 8.02M | 71k | 23.78M | 19.49M | 17.98M |
| Total Liabilities | 4.13M | 5.11M | 16.68M | 21.63M | 26.27M |
| Total Equity | 3.89M | -5.04M | 7.1M | -2.15M | -8.29M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -5.75M | -692k | -3.92M | -2.4M | -1.52M |
| Investing | -2.04M | N/A | 523k | -197k | -65k |
| Financing | 7.8M | 699k | 3.34M | 2.58M | 1.68M |
| Market Cap | 2.44M |
| Price to Earnings Ratio | -0.31 |
| Price to Sales Ratio | 1.04 |
| Price to Cash Ratio | 24.56 |
| Price to Book Ratio | -0.3 |
| Dividend Yield | - |
| Shares Outstanding | 17.65M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 5.75k |
| 52 Week Change | -72.59% |
| 52 Week High | 0.5799 |
| 52 Week Low | 0.096 |
| Spread (Intraday) | 0.09 (46.88%) |
| Company Name | Panacea Life Sciences Holdings Inc (QB) |
| Address |
8275 south eastern avenue #200 las vegas, nevada 89123 |
| Website | https://panacealife.com |
| Industry | medicinal chems,botanicl pds (2833) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
